358 related articles for article (PubMed ID: 17604456)
1. Modulating the expression of disease genes with RNA-based therapy.
Wood M; Yin H; McClorey G
PLoS Genet; 2007 Jun; 3(6):e109. PubMed ID: 17604456
[TBL] [Abstract][Full Text] [Related]
2. Progress toward therapy with antisense-mediated splicing modulation.
Du L; Gatti RA
Curr Opin Mol Ther; 2009 Apr; 11(2):116-23. PubMed ID: 19330717
[TBL] [Abstract][Full Text] [Related]
3. Antisense oligonucleotide-based therapies for diseases caused by pre-mRNA processing defects.
Rigo F; Seth PP; Bennett CF
Adv Exp Med Biol; 2014; 825():303-52. PubMed ID: 25201110
[TBL] [Abstract][Full Text] [Related]
4. Making antisense of splicing.
Garcia-Blanco MA
Curr Opin Mol Ther; 2005 Oct; 7(5):476-82. PubMed ID: 16248283
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of Antisense Drugs.
Bennett CF; Baker BF; Pham N; Swayze E; Geary RS
Annu Rev Pharmacol Toxicol; 2017 Jan; 57():81-105. PubMed ID: 27732800
[TBL] [Abstract][Full Text] [Related]
6. RNA Trans-Splicing Modulation via Antisense Molecule Interference.
Liemberger B; Piñón Hofbauer J; Wally V; Arzt C; Hainzl S; Kocher T; Murauer EM; Bauer JW; Reichelt J; Koller U
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518954
[TBL] [Abstract][Full Text] [Related]
7. The surveillance of pre-mRNA splicing is an early step in
Newman MA; Ji F; Fischer SEJ; Anselmo A; Sadreyev RI; Ruvkun G
Genes Dev; 2018 May; 32(9-10):670-681. PubMed ID: 29739806
[TBL] [Abstract][Full Text] [Related]
8. Splice-switching antisense oligonucleotides as therapeutic drugs.
Havens MA; Hastings ML
Nucleic Acids Res; 2016 Aug; 44(14):6549-63. PubMed ID: 27288447
[TBL] [Abstract][Full Text] [Related]
9. Genetic medicine at the RNA level: modifications of the genetic repertoire for therapeutic purposes by pre-mRNA trans-splicing.
Pergolizzi RG; Crystal RG
C R Biol; 2004 Aug; 327(8):695-709. PubMed ID: 15506518
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Modulation of RNA Splicing in Malignant and Non-Malignant Disease.
El Marabti E; Abdel-Wahab O
Trends Mol Med; 2021 Jul; 27(7):643-659. PubMed ID: 33994320
[TBL] [Abstract][Full Text] [Related]
11. More than a messenger: Alternative splicing as a therapeutic target.
Black AJ; Gamarra JR; Giudice J
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194395. PubMed ID: 31271898
[TBL] [Abstract][Full Text] [Related]
12. RNA splicing manipulation: strategies to modify gene expression for a variety of therapeutic outcomes.
Wilton SD; Fletcher S
Curr Gene Ther; 2011 Aug; 11(4):259-75. PubMed ID: 21453280
[TBL] [Abstract][Full Text] [Related]
13. The notorious R.N.A. in the spotlight - drug or target for the treatment of disease.
Reautschnig P; Vogel P; Stafforst T
RNA Biol; 2017 May; 14(5):651-668. PubMed ID: 27415589
[TBL] [Abstract][Full Text] [Related]
14. Antisense mediated splicing modulation for inherited metabolic diseases: challenges for delivery.
Pérez B; Vilageliu L; Grinberg D; Desviat LR
Nucleic Acid Ther; 2014 Feb; 24(1):48-56. PubMed ID: 24506780
[TBL] [Abstract][Full Text] [Related]
15. Liver as a target for oligonucleotide therapeutics.
Sehgal A; Vaishnaw A; Fitzgerald K
J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
[TBL] [Abstract][Full Text] [Related]
16. RNA splicing manipulation: strategies to modify gene expression for a variety of therapeutic outcomes.
Wilton SD; Fletcher S
Curr Gene Ther; 2005 Oct; 5(5):467-83. PubMed ID: 16250888
[TBL] [Abstract][Full Text] [Related]
17. Clinical Applications of Single-Stranded Oligonucleotides: Current Landscape of Approved and In-Development Therapeutics.
Scharner J; Aznarez I
Mol Ther; 2021 Feb; 29(2):540-554. PubMed ID: 33359792
[TBL] [Abstract][Full Text] [Related]
18. State-of-the-art human gene therapy: part II. Gene therapy strategies and clinical applications.
Wang D; Gao G
Discov Med; 2014 Sep; 18(98):151-61. PubMed ID: 25227756
[TBL] [Abstract][Full Text] [Related]
19. Exon-skipping antisense oligonucleotides to correct missplicing in neurogenetic diseases.
Siva K; Covello G; Denti MA
Nucleic Acid Ther; 2014 Feb; 24(1):69-86. PubMed ID: 24506781
[TBL] [Abstract][Full Text] [Related]
20. Oligonucleotide-based strategies to combat polyglutamine diseases.
Fiszer A; Krzyzosiak WJ
Nucleic Acids Res; 2014 Jun; 42(11):6787-810. PubMed ID: 24848018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
